Postmenopause Supplement Stack: 5 Evidence-Based Supplements for Bone Density, Cardiovascular Health, and Cognitive Longevity

Total cost: ~$90–130/month. Buy individual items, not a bundle.Stack-kit editorial

Here's the short version before the dense part: once your ovaries stop making much estrogen, three clocks start ticking faster at the same time — your bones thin, your heart-disease risk climbs, and your brain's energy machinery slows. The five supplements below push back on all three. Each one comes with a specific compound, a specific dose, a specific brand we'd actually buy, and — just as important — a clear list of who should leave it on the shelf.

What most people get wrong here is treating postmenopause like a vitamin problem to be solved with one big pink "women's" multivitamin. It isn't. It's three separate biological shifts, and the products marketed hardest at this exact buyer (calcium megadoses, iron-loaded multis) are often the ones working against you. We'll get to those.

TL;DR — The Protocol at a Glance

Who this is for: Women ≥12 months past their last period, or with FSH-confirmed surgical menopause. (FSH is follicle-stimulating hormone — the blood marker that climbs and stays high once the ovaries wind down.) This is the postmenopause protocol. Perimenopause — the bumpy transition before periods stop — is a separate cell.

The 5 supplements:

1. Vitamin D3 — 1,000–2,000 IU/day for maintenance/unknown labs; 4,000 IU only with low labs or clinician-guided correction
2. Vitamin K2 MK-7 — 180 mcg/day (not MK-4)
3. Magnesium Glycinate — 300–400 mg elemental/day, split dose
4. Creatine Monohydrate — 3–5 g/day, with resistance training
5. Omega-3 EPA + DHA — 2–3 g/day combined

The non-negotiable caveat: If you are on warfarin, bisphosphonates, statins, thiazide diuretics, or HRT, read the skip-conditions under each supplement before adding anything. Several entries carry hard stops, not soft cautions. We mean hard stops literally — one wrong combination here changes how your blood clots.

HRT note: This stack complements HRT. It does not replace it.

What to cut: Calcium carbonate supplements, women's multivitamins with iron, high-dose retinol above 5,000 IU/day, OTC DHEA, collagen peptides for bone. Details below — and we explain the reasoning, because "just trust us" isn't a reason.

The Protocol — Detailed

Vitamin D3 — Bone and Cardiovascular Foundation

In one line: D3 is the key that unlocks the calcium door in your gut. Skip it, and most of the calcium you eat walks right back out.

Mechanism

Vitamin D3 (cholecalciferol) is the raw material your body converts into calcitriol — the active hormone that tells your intestine to actually absorb the calcium passing through it. Without enough D3, dietary calcium passes through largely unabsorbed regardless of how much you eat. And estrogen withdrawal makes this worse: declining estrogen changes vitamin-D signaling in postmenopausal women, which raises the importance of measuring and correcting a real shortfall rather than guessing.

There's a second, separate reason D3 earns its slot — and it has nothing to do with bone. Deficiency tracks with elevated parathyroid hormone (the hormone that pulls calcium out of bone when blood levels drop) and with stiffer arteries, both of which speed up after estrogen leaves. So D3 is pulling double duty. But understand its limit: D3 alone does not get you bone outcomes. It drives calcium in; Vitamin K2 — the next entry — decides where that calcium goes. Think of them as a relay, not two interchangeable runners.

Dose and Timing

Start with a baseline serum 25(OH)D before you dose aggressively. For maintenance or unknown labs, 1,000–2,000 IU/day is the conservative range. Push to 4,000 IU/day only if your serum 25(OH)D comes back low (especially below 30 ng/mL) or your clinician is correcting a documented deficiency — then recheck at 12 weeks and aim for a conservative 30–50 ng/mL unless your clinician sets a different target. Take it with the fattiest meal of your day: D3 is fat-soluble, meaning it rides into your bloodstream on dietary fat, and that fat co-ingestion bumps absorption by roughly 32% (Mulligan & Bhatt 2010, J Bone Miner Res). Don't pair it with high-fiber supplements in the same meal — fiber drags some of it back out. And if you're on thiazide diuretics, watch your serum calcium: D3 plus thiazides raises hypercalcemia risk.

Brand

Thorne Vitamin D-5000 — 5,000 IU per softgel, NSF Certified for Sport, ~$18/60 softgels — is a high-dose SKU, not a default daily dose. Use every other day for a ~2,500 IU average only when labs justify it, and use daily only under physician monitoring for confirmed deficiency. Prefer a fixed lower daily dose? Pure Encapsulations D3 2,000 IU does that job — USP-verified, ~$22/120 capsules. If your 25(OH)D is already ≥50 ng/mL, skip or reduce rather than topping off.

The Study

Bischoff-Ferrari HA et al. 2012. NEJM 367(1):40–49. Pooled analysis of 11 double-blind RCTs, n=31,022. Vitamin D3 doses ≥800 IU/day cut hip fracture risk by 30% (RR 0.70, 95% CI 0.58–0.86) and any nonvertebral fracture by 14% versus lower-dose or placebo groups. The effect was dose-dependent, and the women who started out deficient saw the biggest absolute gain in the 2,000+ IU range. That last detail is why baseline testing earns its keep — the more deficient you are, the more this matters.

When to Skip

Granulomatous disease — sarcoidosis, active tuberculosis, certain lymphomas. These conditions crank up your body's own (endogenous) calcitriol production, so adding supplemental D3 becomes a hypercalcemia risk no matter what your serum 25(OH)D reads. Also skip it if you've got confirmed serum sufficiency above 60 ng/mL and no history of deficiency — maintenance dosing is low-risk above that line, but you're chasing a benefit that's already mostly banked.

Vitamin K2 MK-7 — Calcium Routing for Bone and Arteries

Plain version: D3 lets calcium into the body; K2 makes sure it ends up in your bones instead of clogging your arteries. They're a pair for a reason.

Mechanism

Vitamin K2 in the MK-7 form switches on two proteins that do load-bearing work for both bone and heart. One is osteocalcin, which directs calcium into the bone matrix. The other is Matrix Gla Protein (MGP), which keeps calcium out of your arterial walls by binding it and clearing it before it can harden into plaque. That's the whole case for stacking K2 with D3: D3 raises the calcium available for absorption, and K2 decides whether it lands in bone or in arterial plaque.

That arterial side matters more after menopause than people realize — calcification rates accelerate once estrogen drops, and K2 is the one non-prescription lever that hits the calcium-routing mechanism head-on. One thing worth getting right: MK-7 is the correct isoform for a once-daily pill because its half-life (how long it stays active in your blood before being cleared) runs about 72 hours, versus MK-4's 1–2 hours. So any product listing MK-4 below 45 mg taken three times daily is delivering levels too low to do the job. Read the label and check the isoform — this is the single most common way this category gets fumbled.

Dose and Timing

180 mcg/day of MK-7. Take it with fat at the same meal as your D3 — both are fat-soluble and co-administration is fine, even ideal. Hard stop: if you're on warfarin or any vitamin K-antagonist anticoagulant, do not add K2 without physician approval. K2 blunts warfarin's blood-thinning effect and will move your INR (the lab number that tracks how thin your blood is). This is a genuine drug interaction, not a precaution we're tacking on to cover ourselves.

Brand

Thorne MenaQ7 — 180 mcg MK-7 per capsule, NSF Certified for Sport, ~$28/60 capsules. That dose matches the Knapen RCT below exactly, which is the point. Thorne's MenaQ7 uses NattoPharma-branded MK-7 — the same ingredient form run in multiple published trials. In this category, where the molecule was sourced matters more than it does almost anywhere else, so we don't treat all MK-7 as equal.

The Study

Knapen MH et al. 2013. Osteoporosis International 24(9):2499–507. Double-blind RCT, n=244 healthy postmenopausal women, 3-year intervention. MK-7 180 mcg/day versus placebo. The MK-7 group showed significantly better osteocalcin carboxylation and slower age-related loss of bone strength at the lumbar spine: stiffness index +0.9% in the MK-7 group versus −1.4% in placebo at year 3 (p=0.013). Femoral neck BMD decline was also significantly attenuated in the women who started with low K status — again, the deficient benefit most.

When to Skip

Warfarin or any vitamin K-antagonist anticoagulant — hard stop, no exceptions without your prescriber. If you're on a bisphosphonate (Fosamax, Reclast), K2 isn't pharmacologically contraindicated, but the combined effect on bone remodeling hasn't been well-characterized in RCTs built to test both agents together. We'd rather say that plainly than pretend the data exists — talk to your prescribing physician before adding it.

Magnesium Glycinate — Bone Structure, Cardiovascular Risk, and Sleep

Quick orientation: most postmenopausal women are quietly running low on magnesium, and it shows up in three places at once — bones, heart, and sleep. The catch is which form you buy.

Mechanism

Roughly 60% of the body's magnesium lives in bone and teeth — so this isn't a trace mineral you can wave off. It's also a cofactor for over 300 enzymatic reactions that bear directly on postmenopause outcomes, including osteoblast function (the cells that build bone), ATP synthesis (how your cells make usable energy), and endothelial nitric oxide production (how blood vessels relax and stay flexible).

Here's the part the standard blood panel hides: postmenopausal women are disproportionately likely to sit below the RDA of 320 mg/day — not from acute deficiency, but from a slow dietary shortfall that chronically nudges parathyroid hormone up and osteoblast activity down, all without ever tripping the "low magnesium" flag on a routine metabolic panel. So you can look fine on paper and still be underfeeding your bones. The cardiovascular angle is separate and additive: across large prospective cohorts, lower dietary and circulating magnesium consistently tracks with higher cardiovascular disease risk. And the glycinate form is specified on purpose — magnesium oxide, the cheapest and most common OTC form, has roughly 4% bioavailability (the fraction your body can actually absorb and use). If there's magnesium oxide in your cabinet right now, that's the one to cut and replace with this.

Dose and Timing

300–400 mg of elemental magnesium per day as glycinate. Split it: 200 mg with dinner, 100–200 mg about 30 minutes before sleep. The evening dose leans on magnesium's mild help with falling asleep — a real, if modest, effect in postmenopausal women — without the daytime grogginess sedatives bring. Hard stop: chronic kidney disease stage 3 or worse. Magnesium is cleared by the kidneys, and when they're impaired it builds up instead of clearing.

Brand

Thorne Magnesium Bisglycinate — 200 mg elemental Mg per 2-capsule serving, NSF Certified for Sport, ~$22/60 servings. Pure Encapsulations Magnesium Glycinate is an equally good alternative, USP-verified, ~$34/90 capsules. No meaningful difference in quality between them — pick on price and capsule count.

The Studies

Cardiovascular: Del Gobbo LC et al. 2013. Journal of the American College of Cardiology 62(23):2105–13. Systematic review and meta-analysis of 16 prospective cohort studies, n=313,041. Higher circulating and dietary magnesium were independently tied to significantly lower cardiovascular disease risk (RR 0.85, 95% CI 0.78–0.92 per 0.2 mmol/L increase in serum magnesium; RR 0.78, 95% CI 0.69–0.89 for dietary magnesium, highest versus lowest quartile).

Bone: Rude RK et al. 2009. Journal of the American College of Nutrition 28(2):131–141. A review documenting that subclinical magnesium deficiency erodes bone mineral density through impaired osteoblast function and elevated PTH secretion — the silent version, the kind that never flags as clinical hypomagnesemia on routine labs. This is the paper behind the "you can test normal and still be short" point above.

When to Skip

CKD stage 3+ — hard stop. If you genuinely hit 320 mg/day of dietary magnesium through dark leafy greens, legumes, and whole grains — and we'd ask you to verify that with a tracking app for one week rather than assume it — then supplementation becomes optional rather than foundational. And if you're on a long-term PPI (proton-pump inhibitor, the heartburn drugs like omeprazole): PPIs cut magnesium absorption, so use the higher end of the dose range and recheck serum magnesium at 12 weeks.

Creatine Monohydrate — Bone Density and Cognitive Longevity

Don't let the gym-bro reputation throw you. Here, creatine isn't about muscle for muscle's sake — it's about letting you train hard enough to keep your bones, and feeding your aging brain a fuel it runs short on.

Mechanism

Creatine's job in a postmenopause longevity protocol has nothing to do with athletic performance. The bone effect is indirect but well-mapped: creatine raises phosphocreatine availability in muscle, which lets you handle heavier loads during resistance training. Those heavier loads are the main mechanical signal that tells postmenopausal bone to hold its density. The training co-condition isn't fine print — it's the whole mechanism. No mechanical loading, no bone benefit. We'll repeat that, because it's the one place people waste their money on this entry.

The brain effect runs on a different track entirely: creatine supplementation raises brain creatine stores, and the evidence points to that brain creatine supporting executive function and episodic memory in older adults as the brain's energy metabolism gets less efficient with age. Postmenopausal women are honestly an under-studied group in creatine research — but both the bone and cognitive evidence have firmed up considerably since 2020. So don't pass on creatine because it reads like a bodybuilding supplement on the shelf. That's a shelving error, not a clinical contraindication.

Dose and Timing

3–5 g/day of creatine monohydrate. Skip the loading phase — that front-loaded high-dose week is for athletes peaking for competition, and the GI distress it causes buys you nothing on a long-timeline intervention like this one. At 5 g/day, your muscle creatine stores fill up (saturate) in about 3–4 weeks on their own. Take it any time of day with water; at maintenance doses, timing doesn't meaningfully change absorption.

Critical co-condition: this supplement produces bone density outcomes only in combination with resistance training at least 2× per week. Without mechanical loading, the bone signal simply isn't there. If resistance training isn't in your week yet, that habit outranks this supplement — build it first.

Brand

Thorne Creatine — 5 g monohydrate per serving, NSF Certified for Sport, ~$44/90 servings. Momentous Creatine is an equally good NSF-certified alternative at ~$40/30 servings. Plain monohydrate is the entire game here; the fancier "advanced" creatine formats charge more for no added evidence.

The Studies

Bone: Chilibeck PD et al. 2017. Open Access Journal of Sports Medicine 8:213–226. Meta-analysis of 22 RCTs on creatine combined with resistance training in adults ≥50 years. Creatine + resistance training preserved significantly more lean mass and bone mineral content than resistance training alone; postmenopausal women across the included trials showed slower bone mineral density loss over the intervention period. Note the structure of that finding — it's creatine plus training, never creatine alone.

Cognitive: Prokopidis K et al. 2023. Nutrition Reviews 81(4):416–427. Systematic review and meta-analysis of 10 RCTs, n=461, weighted toward older adults. Creatine supplementation improved memory performance (SMD 0.34, 95% CI 0.12–0.56; p=0.003); the effect was largest in older-adult subgroups and on tasks leaning on working memory and episodic recall.

When to Skip

Confirmed renal insufficiency (eGFR < 60). Creatine isn't nephrotoxic at evidence-based doses in healthy kidneys, but the trial data in impaired renal function is thin — clear it with your nephrologist first. One more thing to flag rather than fear: creatine causes a transient bump in intracellular water of 0.5–1 kg over the first 2–3 weeks. That's normal and temporary, but if you're managing fluid balance for a cardiac condition, mention it to your physician before starting.

Omega-3 EPA + DHA — Cardiovascular, Bone Resorption, and Cognitive Maintenance

This is the one compound in the stack that pulls on all three levers at once — heart, bone, and brain. If you only had budget for one entry and the cardiovascular clock is what worries you, this is where the evidence is strongest.

Mechanism

Marine-derived omega-3 fatty acids work across all three risk domains in this cell, so it's worth taking them one at a time.

Cardiovascular: EPA lowers triglycerides (a blood fat tied to heart risk) and tamps down platelet clumping; DHA improves membrane fluidity in the vascular endothelium (the inner lining of your blood vessels); both quiet the systemic inflammation that feeds atherosclerosis. Since the cardiovascular shift after estrogen withdrawal is the dominant long-term mortality risk for postmenopausal women, this is the compound aimed most directly at the thing most likely to matter.

Bone: Omega-3s lower prostaglandin E2 and the pro-inflammatory cytokines (IL-1β, IL-6, TNF-α) that rev up osteoclast activity — osteoclasts being the cells that break bone down. The anti-resorptive effect is indirect but consistent across human data. A 2012 systematic review (Poulsen RC et al., Nutrients) across 14 RCTs found omega-3 supplementation linked to improved markers of bone resorption in postmenopausal cohorts.

Cognitive: DHA is the dominant structural fatty acid in neuronal membranes — your neurons are partly built out of it. In older adults with age-related memory changes, DHA supplementation produces consistent episodic memory improvements across RCTs, including MIDAS (Yurko-Mauro K et al. 2010, Alzheimer's & Dementia) and the replications that followed.

Dose and Timing

2 g/day of combined EPA + DHA as the maintenance dose; 3 g/day if cardiovascular risk reduction is your main goal. The EPA-to-DHA ratio matters less here than it would in a pure cardiovascular protocol — for this multi-domain cell, the standard 2:1 EPA:DHA ratio (what most quality fish oils already are) is fine. Take it with the fattiest meal of the day, since fat co-ingestion meaningfully boosts EPA/DHA absorption. And refrigerate the capsules: oxidized fish oil delivers degraded bioavailability and announces its own rancidity with an off-flavor. If it tastes wrong, it's gone off — toss it.

Anticoagulant interaction: at doses ≥3 g/day, omega-3s add to the anti-platelet effect of anticoagulants and antiplatelet agents (warfarin, clopidogrel, aspirin therapy). If you're on any of those, flag it with your physician.

Brand

Nordic Naturals Ultimate Omega — 2,150 mg combined EPA + DHA per 2-softgel serving, IFOS 5-star certified for purity and oxidation, ~$45/60 softgels. That IFOS certification means the product has been independently tested for PCBs, dioxins, heavy metals, and oxidation markers — and in fish oil, that verification matters more than any claim printed on the front of the bottle. Oxidation is the quiet failure mode in this category, which is exactly what IFOS catches. Carlson Super Omega-3 is a comparable IFOS-certified alternative at a lower price point.

The Studies

Cardiovascular: REDUCE-IT trial (Bhatt DL et al. 2019, NEJM 380:11–22) — n=8,179, patients with elevated triglycerides already on statin therapy. Icosapentaenoic acid (EPA-only) at 4 g/day cut major adverse cardiovascular events by 25% versus placebo (RR 0.75, 95% CI 0.68–0.83). Read that one honestly, though: REDUCE-IT used prescription-grade EPA-only (Vascepa) at 4 g/day — a higher, more concentrated dose than this stack. The OTC maintenance dose here carries a more modest cardiovascular effect. Cite this trial for mechanism plausibility, not for dose-for-dose equivalence. We'd rather you know that than overestimate what a softgel does.

Cognitive: Yurko-Mauro K et al. 2010. Alzheimer's & Dementia 6(6):456–464. Double-blind RCT, n=485 older adults with age-related cognitive complaints, 24 weeks. DHA 900 mg/day versus placebo. Episodic memory improved significantly in the DHA group versus placebo (p=0.02), and the effect was sharpest in participants who started with the lowest DHA status.

When to Skip

Confirmed fish or shellfish allergy — go with algae-derived DHA/EPA (e.g., Ovega-3) and skip fish oil entirely. If you're on high-dose anticoagulant therapy, get physician clearance before adding ≥2 g/day. And don't skip this one just because you eat oily fish twice a week — dietary omega-3 at typical Western intake rarely reaches 2 g of EPA + DHA per day, so verify with a tracking app before you assume your dinner has it covered.

What to Cut — And Why

This is the section that separates an honest protocol from a storefront. Every product below is marketed hard at exactly this buyer, and every one of them earns a cut. Here's the reasoning, item by item.

Calcium Carbonate Supplements

The case for supplemental calcium in postmenopausal bone health is weaker than the marketing has trained everyone to assume — and the downside is real, not theoretical. A 2016 meta-analysis (Bolland MJ et al., BMJ 353:i4919) found calcium supplementation without vitamin D associated with a statistically significant rise in heart-attack risk (RR 1.24, 95% CI 1.07–1.45). Calcium from food — dairy, leafy greens, legumes, fortified plant milks — does not carry that cardiovascular signal. The working theory is that a big bolus pill creates short hypercalcemia spikes that nudge calcium toward arterial walls, while food-borne calcium drips into the bloodstream slowly enough to avoid it. Vitamin K2 helps reroute calcium from arteries to bone, but it doesn't fully cancel this dynamic. So: fix dietary calcium first, and supplement only under physician guidance — with K2 alongside it — if testing confirms a real deficiency.

Women's Multivitamins with Iron

Postmenopausal women don't menstruate, so iron loss is minimal — yet the multivitamin aisle is still full of formulas built around premenopausal biology. Excess iron is pro-oxidant at the tissue level and independently tracks with higher cardiovascular disease risk in postmenopausal women (Qi L et al. 2007, Circulation). Flip your bottle over and read the iron content. If it's in there, swap it for a post-50 formulation without iron — most quality brands make one.

High-Dose Retinol Above 5,000 IU/Day

Preformed vitamin A (retinol) competes with vitamin D at the receptor level and, at sustained high doses, tracks with lower bone mineral density — which is the opposite of what you're trying to do here. The risk threshold in the literature starts around 5,000–10,000 IU/day of retinol from supplements. This is specifically the retinol form, not beta-carotene, which your body converts to retinol on demand and which doesn't carry the same risk. Check your multivitamin and any standalone A supplement for the retinol form; if your combined retinol exposure tops 5,000 IU/day while you're running a bone-density protocol, pull it back.

OTC DHEA Without Physician Oversight

DHEA is a precursor to both estrogen and testosterone, and the premise behind taking it OTC — topping up the adrenal DHEA that declines with age — is physiologically coherent. We'll grant that much. The problem is execution: OTC dosing is imprecise, the androgenic side effects in postmenopausal women are variable and poorly characterized outside clinical supervision, and a bottle off the shelf does not substitute for an actual HRT decision made with a prescriber. If DHEA is right for you, that's a conversation with your physician — not a checkout cart. Until you've had it, skip it.

Collagen Peptides for Bone

The proposed mechanism — collagen peptide hydrolysates supplying building blocks for the bone's protein scaffold — is biologically plausible, and we're not dismissing it. But as of 2026, the RCT evidence specifically in postmenopausal women for BMD outcomes isn't strong enough to clear this protocol's bar. A 2023 systematic review (Khatri M et al., Nutrients 15(3):696) found improvements in bone metabolism markers but flagged that most of the trials were small, short, and lacked DXA-confirmed BMD endpoints. We're watching this one — it may earn a slot in a future revision. It just hasn't yet.

FAQ

Does this stack work if I'm already on HRT?

Yes — and the two together beat either one alone. HRT goes straight at estrogen withdrawal; the supplements here work through mechanisms that are at least partly independent of estrogen. K2's activation of Matrix Gla Protein, creatine's support of muscle-driven mechanical loading on bone, and omega-3's cardiovascular anti-inflammatory effect aren't estrogen-mediated, so they're adding coverage HRT doesn't. There are no pharmacological contraindications between this stack and standard HRT formulations (oral estrogen, transdermal estrogen, progesterone). One exception worth raising: if your HRT regimen includes an oral progesterone compound that affects vitamin K activity — uncommon, but possible — flag it with your physician.

I'm on a bisphosphonate (Fosamax, Reclast, Boniva). Do I still need the bone supplements?

Bisphosphonates work one lever: they suppress osteoclast activity to slow bone resorption. They do nothing for calcium absorption (D3's job), calcium routing (K2's job), or the mechanical loading stimulus (creatine's supporting role). So the combination is complementary, not redundant. The one caveat: the K2 entry carries a physician-consultation flag for bisphosphonate users, because the RCT data on combined bone-remodeling effects is limited. The other three bone-relevant supplements — D3, magnesium, creatine — carry no bisphosphonate contraindication.

How long before I notice a difference?

Mostly, you won't feel it — and that's the honest answer, not a dodge. Bone mineral density shifts on a 12–24-month timescale, measured by DXA scan, not by sensation. That's the correct expectation. Cardiovascular markers move faster: expect measurable lipid-panel changes from omega-3 at 8–12 weeks. Magnesium's sleep benefit, if you get one, usually shows up within 2–4 weeks. Creatine saturates muscle in about 3–4 weeks at 5 g/day. This is a long-horizon investment in your sixties and seventies, not a 30-day before-and-after.

Can I start all five at once?

You can. But if you're prone to a sensitive stomach, adding one compound per week makes troubleshooting far easier — if something irritates your gut in the first two weeks, you'll know which one. The usual suspects are magnesium (loose stools at higher doses; just drop the dose and titrate back up) and omega-3 capsules (fishy burp-back; refrigerate them and take with food). Creatine at 5 g/day without a loading phase sits well with most people.

What if I don't do resistance training?

Then drop creatine. Its bone-density benefit lives entirely in the mechanical loading that resistance training provides — without it, you're paying for a sharply diminished effect in that domain. The cognitive mechanism is training-independent, true, but 3–5 g/day for cognition alone is a thin proposition at this price. The better move: prioritize the training. Even 2× per week at moderate intensity produces meaningful BMD effects — get that pattern going, then add creatine on top of it.

I've seen soy isoflavones and black cohosh recommended for postmenopause. Why aren't they here?

Because they're aimed at a different problem. Soy isoflavones and black cohosh target vasomotor symptoms — hot flashes, night sweats — which are perimenopause and early-postmenopause complaints. This protocol is scoped to the three risk tracks that persist and compound deep into postmenopause: bone density, cardiovascular risk, and cognitive longevity. If hot flashes are still hitting you and disrupting life, that's a separate protocol conversation, not a hole in this one.

Is the omega-3 evidence strong enough to justify the cost?

Its cardiovascular mechanism is the strongest evidence in this entire stack — so if anything earns its price, it's this. REDUCE-IT showed a 25% drop in major adverse cardiovascular events at high EPA doses in high-risk patients. At the OTC maintenance dose here (2–3 g/day combined EPA + DHA), the absolute cardiovascular effect is more modest — we're not going to pretend a softgel matches a prescription. But the risk-to-benefit ratio for omega-3 at these doses is among the most favorable in the entire non-prescription category, and the bone and cognitive co-benefits make the cost-per-outcome math work for a multi-domain protocol like this.

Affiliate Disclosure

Stack-kit earns commission on purchases made through affiliate links on this page. Thorne, Momentous, Nordic Naturals, Pure Encapsulations, and Carlson earned their slots through evidence quality and third-party testing standards — not affiliate rate, not paid placement. The proof is the section above: we name what to cut even when those cuts are popular, profitable products. If a better-evidenced product ever displaces a current pick, we update the protocol and the links.

We don't accept payment for protocol inclusion. We don't run sponsored content or brand partnerships that would have us recommend something we otherwise wouldn't. Affiliate commission is the only commercial relationship this publication has with the brands named here. You pay the same price either way.

This protocol is educational content only. None of this constitutes medical advice. Supplement decisions for postmenopausal women — particularly anyone managing bone density loss or elevated cardiovascular risk — warrant physician oversight before starting. If you are on HRT, statins, bisphosphonates, warfarin or any anticoagulant, thiazide diuretics, or calcium channel blockers, verify these choices with your prescribing physician before adding anything in this stack.